BackSanten Pharmaceutical , Ltd. Overview

Santen Pharmaceutical , Ltd. Total Liabilities

Latest total liabilities for SNPHF: $120B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$115.12B
↑ 14640.27% YoYΔ $114.34B vs prior year quarter

Peer trimmed avg / median

Loading

Santen Pharmaceutical , Ltd. Total Liabilities History

Loading

Santen Pharmaceutical , Ltd. vs. peers: Total Liabilities Comparison

Loading

Santen Pharmaceutical , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Santen Pharmaceutical , Ltd. (SNPHF) FAQ

As of the most recent data (September 2026), SNPHF shows a total liabilities of $120B. That compares with $780M in the prior-year period — up 14640.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SNPHF's total liabilities is now $120B (was $780M) — a 14640.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Santen Pharmaceutical , Ltd. is outperforming or lagging.

Tracking SNPHF's total liabilities over time shows whether Santen Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $120B That compares with $780M in the prior-year period — up 14640.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Santen Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $120B) with ownership activity and broader fundamentals.